- Filed
- Mar 20, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Mar 17, 2025 | 98.12M sh |
| Shares Diluted | FY 2024 · Dec 31, 2023 | 95.22M sh |
| Capex | FY 2024 · Dec 31, 2023 | $175K |
| Operating Cash Flow | FY 2024 · Dec 31, 2023 | −$59.27M |
| Short Term Investments | FY 2024 · Dec 31, 2023 | $157.39M |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $70.97M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $2.39M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $2.43M |
| Current Assets | FY 2024 · Dec 31, 2023 | $231.73M |
| Total Assets | FY 2024 · Dec 31, 2023 | $233.19M |
| Eps Diluted | FY 2024 · Dec 31, 2023 | −$0.57 |
| Eps Basic | FY 2024 · Dec 31, 2023 | −$0.57 |
| Sga Expense restated | FY 2024 · Dec 31, 2023 | $47.28M |
| Rd Expense | FY 2024 · Dec 31, 2023 | $20.27M |
| Net Income | FY 2024 · Dec 31, 2023 | −$54.37M |
| Operating Income | FY 2024 · Dec 31, 2023 | −$67.52M |
| Cost Of Revenue | FY 2024 · Dec 31, 2023 | $0 |
| Revenue | FY 2024 · Dec 31, 2023 | $30K |
| Stockholders Equity | FY 2024 · Dec 31, 2022 | $272.89M |